NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Dutch scientists dampen diabetes hype

Posted By

Tags

A Dutch epidemiologist and colleagues warn in the BMJ this week that news coverage of a diabetes finding may raise unrealistic expectations. They write that a New York Times story earlier this year quoted a diabetes researcher saying the gene discovery (a variant of the TCF7L2 or transcription factor 7-like 2 gene) could lead to a diagnostic test to identify people who carry the variant gene.

They say that a Scottish scientist headed the research team, which led the Glasgow Herald to report, “Discovery of holy grail will help scientists treat diabetes.”

The editorial acknowledges that the discovery is undeniably noteworthy. But the claim that this discovery will lead to a diagnostic test – and the chance to prevent type 2 diabetes – may not be true and may mislead the public.

“Raising unrealistic expectations – even inadvertently – could distract attention from what can be done by applying what we already know to prevent diabetes and its complications,” they conclude.

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.